Showing results (721-730 of 1,099) with videos related to

Sort By:
Pageof 110
Heart Rhythm|May 2, 2020
Physical activity and atrial fibrillation: Data from wearable fitness trackersSarah Semaan, Thomas A Dewland, Geoffrey H Tison, et al.
Retina (Philadelphia, Pa.)|December 22, 1999
Sham radiation in clinical trials assessing radiotherapy for exudative age-related macular degenerationD M Marcus, M W Camp, W C Sheils, et al.
Annals of Family Medicine|March 14, 2012
Lung cancer screening practices of primary care physicians: results from a national surveyCarrie N Klabunde, Pamela M Marcus, Paul K J Han, et al.
American Heart Journal|December 16, 2014
Procedure timing as a predictor of inhospital adverse outcomes from implantable cardioverter-defibrillator implantation: insights from the National Cardiovascular Data RegistryJonathan C Hsu, Paul D Varosy, Craig S Parzynski, et al.
The Canadian Journal of Urology|December 12, 2012
Salvage therapy for locally recurrent prostate cancer after radiationDavid M Marcus, Daniel J Canter, Ashesh B Jani, et al.
Heart Rhythm|March 3, 2015
Clinical and electrocardiographic characteristics of idiopathic ventricular arrhythmias with right bundle branch block and superior axis: Comparison of apical crux area and posterior septal left ventricleMitsuharu Kawamura, Jonathan C Hsu, Vasanth Vedantham, et al.
Nature Medicine|August 19, 2020
A digital biomarker of diabetes from smartphone-based vascular signalsRobert Avram, Jeffrey E Olgin, Peter Kuhar, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 15, 2001
External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration: one-year results of a prospective, double-masked, randomized clinical trialD M Marcus, W Sheils, M H Johnson, et al.
Hormone Research in Paediatrics|September 4, 2010
Associations of progesterone receptor polymorphisms with age at menarche and menstrual cycle lengthK C Taylor, C M Small, M P Epstein, et al.
ACS Pharmacology & Translational Science|November 21, 2022
Preclinical Characterization and Development on NAQ as a Mu Opioid Receptor Partial Agonist for Opioid Use Disorder TreatmentPiyusha P Pagare, Samuel Obeng, Boshi Huang, et al.
Pageof 110